VALIDATION OF INDONESIAN VERSION OF IPSS
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: This study aims to validate the Indonesian version of International Prostate Symptom Score (IPSS)to ensure similar purpose and quality as the original version. Material & method: Validation and reliability of IPSS-Ina was performed on 174 subjects divided into 87 benign prostate hyperplasia(BPH) patients and 87 non-BPH subjects as a control group. A total of 33 patients in the BPH group then underwent TURP. Validation was assessed by correlating the IPSS score-Ina with a quality of life score (QoL). Reliability was tested by internal consistency with Cronbach α and test-retest trials. Sensitivity to changes in IPSS-Ina post-therapy was tested by comparing the mean IPSS before and after transurethral resection of the prostate (TURP) therapy. Results: Correlation between IPSS-Ina score with quality of life (QoL) was 0.85 (p <0.001),showing strong correlation.Results of Cronbach's α 0.93; while test-retest trials with the intraclass correlation coefficient (ICC) 0.99; which indicates a very good reliability. The mean initial IPSS-Ina (20.97 ± 4.4) with post-TURP (4.82 ± 1.77) differed significantly (p <0.001). Conclusion: IPSS-Ina proved excellent validation and reliability and was sensitive to symptomatic changeafter therapy. IPSS-Ina have the same goals and the quality of the original version.Keywords: International prostate symptom score, Indonesia, validation, reliability.
##plugins.themes.bootstrap3.article.details##
Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990; 17(3): 495-507.
Roehrborn, Claus G. Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history, in Wein, Alan J, et al (ed). Campbell-Walsh Urology. 10th Ed. Philadelphia: Elsevier Saunders; 2012. p. 2584.
Subdirektorat Layanan & Promosi Statistik. Perkembangan beberapa indikator utama sosial-ekonomi Indonesia. Jakarta: Badan Pusat Statistik; 2010.
Cockett AT, Aso Y, Denis L, Khoury S, Barry M, Carlton CE, et al. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol. 1991; 1(6): 957-72.
Badia X, Garcia-Losa M, Dal-Re R. Ten-language translation and harmonization of the International Prostate Symptom Score: Developing a methodology for multinational clinical trials. Eur Urol. 1997; 31(2): 129-40.
Badia X, Garcia-Losa M, Dal-Re R, Carballido J, Serra M. Validation of a harmonized Spanish version of the IPSS: Evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology. 1998; 52(4): 614-20.
Quek KF, Low WY, Razack AH, Sin Loh C, Chua CB. Reliability and validity of the Malay version of the International Prostate Symptom Score in the Malaysian population. J Urol. 2002; 167(3): 1359-62.
Barry MJ, Fowler FJ, Jr., O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992; 148(5): 1549-57; discussion 64.